Physician

Yoshihiro Yonekawa, M.D.

According to 2025 Medicare claims, Yoshihiro Yonekawa, M.D. (NPI: 1962727008) practices ophthalmology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Northampton, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 18017-9412.

Yonekawa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,524 traditional Medicare patients, billed 57,880 HCPCS/CPT codes, and received $6,991,340 in Medicare payments. The top billing code was Q5128 (Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg). Part D data shows 490 prescription claims across 146 beneficiaries totaling $28,997 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 58 records totaling $189,741. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $63,328 to $6,991,340. Similarly, Part D prescription costs have risen steadily, from $20,175 to $28,997. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	215	471	$63,328
2016	201	648	$50,182
2017	274	1,611	$113,329
2018	302	1,655	$108,391
2019	710	4,163	$779,562
2020	1,186	14,757	$3,139,961
2021	1,332	19,700	$4,058,033
2022	1,654	27,462	$5,136,580
2023	1,557	44,230	$6,429,308
2024	1,524	57,880	$6,991,340

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	171	523	$20,175
2016	89	266	$7,557
2017	13	30	$2,532
2018	18	56	$3,468
2019	45	101	$7,022
2020	139	483	$25,679
2021	163	544	$33,209
2022	142	496	$57,319
2023	137	381	$31,851
2024	146	490	$28,997

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	316	12,877	$181
67028	Injection of drug into eye	586	3,923	$104
92014	Established patient complete exam of visual system	657	775	$87
92012	Established patient problem focused exam of visual system	882	2,971	$69
92134	Imaging of retina	1,452	5,487	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	178	7,109	$8,748
Bromfenac Sodium	Bromfenac Sodium	35	1,285	$4,770
Loteprednol Etabonate	Loteprednol Etabonate	12	794	$3,308
Ketorolac Tromethamine	Ketorolac Tromethamine	47	1,496	$1,360
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	43	2,550	$549

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$10,777	F. Hoffmann-La Roche AG
Research Payments	Reported research-related payment or transfer-of-value amount.	50	$178,964	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Yoshihiro Yonekawa, M.D.?

Tedicare shows public-source Medicare data for Yoshihiro Yonekawa, M.D. (NPI 1962727008), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Yoshihiro Yonekawa, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Yoshihiro Yonekawa, M.D.?

Yoshihiro Yonekawa, M.D. is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Yoshihiro Yonekawa, M.D. have Open Payments data?

Yoshihiro Yonekawa, M.D. has 58 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.